1. Home
  2. DTM vs ROIV Comparison

DTM vs ROIV Comparison

Compare DTM & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DT Midstream Inc.

DTM

DT Midstream Inc.

HOLD

Current Price

$119.88

Market Cap

12.3B

Sector

Utilities

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$22.87

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTM
ROIV
Founded
2021
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3B
14.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DTM
ROIV
Price
$119.88
$22.87
Analyst Decision
Buy
Strong Buy
Analyst Count
11
8
Target Price
$124.91
$24.31
AVG Volume (30 Days)
636.8K
6.9M
Earning Date
02-25-2026
02-09-2026
Dividend Yield
2.72%
N/A
EPS Growth
N/A
N/A
EPS
3.96
N/A
Revenue
$1,175,000,000.00
$20,329,000.00
Revenue This Year
$27.83
N/A
Revenue Next Year
$8.45
$741.42
P/E Ratio
$30.42
N/A
Revenue Growth
20.39
N/A
52 Week Low
$83.30
$8.73
52 Week High
$122.70
$23.91

Technical Indicators

Market Signals
Indicator
DTM
ROIV
Relative Strength Index (RSI) 54.72 57.80
Support Level $116.82 $21.57
Resistance Level $119.62 $23.91
Average True Range (ATR) 2.47 0.73
MACD -0.26 0.08
Stochastic Oscillator 66.21 66.28

Price Performance

Historical Comparison
DTM
ROIV

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: